Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 1
2003 1
2005 3
2006 1
2008 1
2011 1
2012 3
2013 2
2014 2
2015 2
2017 4
2018 4
2019 5
2020 14
2021 13
2022 16
2023 23
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

89 results

Results by year

Filters applied: . Clear all
Page 1
Artificial intelligence for diabetic retinopathy screening: a review.
Grzybowski A, Brona P, Lim G, Ruamviboonsuk P, Tan GSW, Abramoff M, Ting DSW. Grzybowski A, et al. Among authors: ruamviboonsuk p. Eye (Lond). 2020 Mar;34(3):451-460. doi: 10.1038/s41433-019-0566-0. Epub 2019 Sep 5. Eye (Lond). 2020. PMID: 31488886 Free PMC article. Review.
Efficacy, durability, and safety of intravitreal faricimab with extended dosing up to every 16 weeks in patients with diabetic macular oedema (YOSEMITE and RHINE): two randomised, double-masked, phase 3 trials.
Wykoff CC, Abreu F, Adamis AP, Basu K, Eichenbaum DA, Haskova Z, Lin H, Loewenstein A, Mohan S, Pearce IA, Sakamoto T, Schlottmann PG, Silverman D, Sun JK, Wells JA, Willis JR, Tadayoni R; YOSEMITE and RHINE Investigators. Wykoff CC, et al. Lancet. 2022 Feb 19;399(10326):741-755. doi: 10.1016/S0140-6736(22)00018-6. Epub 2022 Jan 24. Lancet. 2022. PMID: 35085503 Clinical Trial.
Reply.
Teo KYC, Kokame G, Sadda SR, Fujimoto S, Gomi F, Kim JE, Cheng MFS, Corradetti G, Amornpetchsathaporn A, Chainakul M, Lee WK, Lai TYY, Ruamviboonsuk P, Cheung CMG. Teo KYC, et al. Among authors: ruamviboonsuk p. Ophthalmol Retina. 2023 Jul;7(7):e10-e11. doi: 10.1016/j.oret.2023.03.013. Epub 2023 Apr 20. Ophthalmol Retina. 2023. PMID: 37086256 No abstract available.
Polypoidal Choroidal Vasculopathy: Consensus Nomenclature and Non-Indocyanine Green Angiograph Diagnostic Criteria from the Asia-Pacific Ocular Imaging Society PCV Workgroup.
Cheung CMG, Lai TYY, Teo K, Ruamviboonsuk P, Chen SJ, Kim JE, Gomi F, Koh AH, Kokame G, Jordan-Yu JM, Corvi F, Invernizzi A, Ogura Y, Tan C, Mitchell P, Gupta V, Chhablani J, Chakravarthy U, Sadda SR, Wong TY, Staurenghi G, Lee WK. Cheung CMG, et al. Among authors: ruamviboonsuk p. Ophthalmology. 2021 Mar;128(3):443-452. doi: 10.1016/j.ophtha.2020.08.006. Epub 2020 Aug 11. Ophthalmology. 2021. PMID: 32795496 Free article.
Guidelines on Diabetic Eye Care: The International Council of Ophthalmology Recommendations for Screening, Follow-up, Referral, and Treatment Based on Resource Settings.
Wong TY, Sun J, Kawasaki R, Ruamviboonsuk P, Gupta N, Lansingh VC, Maia M, Mathenge W, Moreker S, Muqit MMK, Resnikoff S, Verdaguer J, Zhao P, Ferris F, Aiello LP, Taylor HR. Wong TY, et al. Among authors: ruamviboonsuk p. Ophthalmology. 2018 Oct;125(10):1608-1622. doi: 10.1016/j.ophtha.2018.04.007. Epub 2018 May 24. Ophthalmology. 2018. PMID: 29776671 Review.
Faricimab Treat-and-Extend for Diabetic Macular Edema: Two-Year Results from the Randomized Phase 3 YOSEMITE and RHINE Trials.
Wong TY, Haskova Z, Asik K, Baumal CR, Csaky KG, Eter N, Ives JA, Jaffe GJ, Korobelnik JF, Lin H, Murata T, Ruamviboonsuk P, Schlottmann PG, Seres AI, Silverman D, Sun X, Tang Y, Wells JA, Yoon YH, Wykoff CC; YOSEMITE and RHINE Investigators. Wong TY, et al. Among authors: ruamviboonsuk p. Ophthalmology. 2024 Jun;131(6):708-723. doi: 10.1016/j.ophtha.2023.12.026. Epub 2023 Dec 28. Ophthalmology. 2024. PMID: 38158159 Free article. Clinical Trial.
YOSEMITE and RHINE: Phase 3 Randomized Clinical Trials of Faricimab for Diabetic Macular Edema: Study Design and Rationale.
Eter N, Singh RP, Abreu F, Asik K, Basu K, Baumal C, Chang A, Csaky KG, Haskova Z, Lin H, Ruiz CQ, Ruamviboonsuk P, Silverman D, Wykoff CC, Willis JR. Eter N, et al. Among authors: ruamviboonsuk p. Ophthalmol Sci. 2021 Dec 30;2(1):100111. doi: 10.1016/j.xops.2021.100111. eCollection 2022 Mar. Ophthalmol Sci. 2021. PMID: 36246184 Free PMC article.
Large language models and their impact in ophthalmology.
Betzler BK, Chen H, Cheng CY, Lee CS, Ning G, Song SJ, Lee AY, Kawasaki R, van Wijngaarden P, Grzybowski A, He M, Li D, Ran Ran A, Ting DSW, Teo K, Ruamviboonsuk P, Sivaprasad S, Chaudhary V, Tadayoni R, Wang X, Cheung CY, Zheng Y, Wang YX, Tham YC, Wong TY. Betzler BK, et al. Among authors: ruamviboonsuk p. Lancet Digit Health. 2023 Dec;5(12):e917-e924. doi: 10.1016/S2589-7500(23)00201-7. Lancet Digit Health. 2023. PMID: 38000875 Free PMC article. Review.
Evolving treatment paradigms for PCV.
Fenner BJ, Cheung CMG, Sim SS, Lee WK, Staurenghi G, Lai TYY, Ruamviboonsuk P, Kokame G, Yanagi Y, Teo KYC. Fenner BJ, et al. Among authors: ruamviboonsuk p. Eye (Lond). 2022 Feb;36(2):257-265. doi: 10.1038/s41433-021-01688-7. Epub 2021 Jul 14. Eye (Lond). 2022. PMID: 34262165 Free PMC article. Review.
Ophthalmology and COVID-19: Long-term Surveillance Needed.
Radke N, Ruamviboonsuk P, Tham CCY, Jonas JB, Lam DSC. Radke N, et al. Among authors: ruamviboonsuk p. Asia Pac J Ophthalmol (Phila). 2021 Nov-Dec 01;10(6):519-520. doi: 10.1097/APO.0000000000000449. Asia Pac J Ophthalmol (Phila). 2021. PMID: 34905517 Free article. No abstract available.
89 results